Maternal folate exposure in pregnancy and childhood asthma and allergy: a systematic review

Nutrition Reviews
|February 21, 2014
PubMed

Insights

Maternal folic acid supplementation in pregnancy may have a small, transient impact on childhood asthma risk, particularly when taken late in pregnancy. More research is needed to clarify this association.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatric Allergy and Immunology
  • Nutritional Epidemiology

Background:

  • Adequate maternal folate status is crucial for preventing congenital malformations.
  • The impact of folic acid supplementation, especially exceeding recommended doses, on long-term child health remains unclear.
  • Conflicting evidence exists regarding maternal folate levels and the risk of childhood asthma and allergic diseases.

Purpose of the Study:

  • To systematically review the epidemiologic evidence linking maternal folate exposure to childhood asthma and allergic disease.
  • To synthesize findings from prospective cohort studies, considering methodological variations and limitations.
  • To provide direction for future research on this topic.

Main Methods:

  • Systematic review of 10 large prospective cohort studies.
  • Analysis of epidemiologic data on maternal folate levels and childhood asthma/allergic disease risk.
  • Evaluation of study methodologies and potential limitations.

Main Results:

  • The majority of studies found no significant association between maternal folate levels and childhood asthma or allergic disease.
  • A small, transient increase in risk was observed in some studies, primarily linked to late-pregnancy folic acid supplementation.
  • The observed associations were generally confined to early childhood.

Conclusions:

  • Current evidence on the link between maternal folate exposure and childhood asthma is conflicting.
  • A potential transient increase in risk may be associated with late-pregnancy folic acid supplementation.
  • Further research is warranted to elucidate the complex relationship and potential confounding factors.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.8K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65